HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota.

Abstract
Vitamin B (nicotinamide (NAM)), one of the most important nutritional components for humans, exerts anti-inflammatory activity. This study was aimed at investigating the effect of NAM on the gut microbiota and short-chain fatty acids (SCFAs) in mice with chronic colitis. Colitis was induced in C57BL/6 male mice by administration of 1.5% dextran sulfate sodium (DSS), and the mice were intraperitoneally injected with normal saline (NS) or NAM. NAM treatment ameliorated weight loss and changes in colon length, disease activity index (DAI) score, and histologic scores. Moreover, enzyme-linked immunosorbent assay (ELISA) analysis of LPL cells revealed that the level of interleukin- (IL-) 6, IL-12p70, IL-1β, tumor necrosis factor- (TNF-) α, interferon- (IFN-) γ, IL-21, and IL-17A was increased, while IL-10 was reduced, in the chronic colitis group compared to the control group, but the levels of all these factors were restored after NAM treatment. Then, 16S rRNA sequencing of the large intestinal content was performed, and analysis of alpha diversity and beta diversity showed that the richness of the gut microbiota was decreased in the DSS group compared to the control group and restored after NAM treatment. In addition, NAM modulated specific bacteria, including Odoribacter, Flexispira, and Bifidobacterium, in the NAM+chronic colitis group. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) analysis indicated that NAM treatment restored disruptions in the functions of the gut microbiota (replication and repair, cell motility) in mice with DSS-induced colitis. Furthermore, NAM also restored the reduction in valeric acid in mice with DSS-induced chronic colitis. Our results suggest that NAM treatment could alleviate DSS-induced chronic colitis in mice by inhibiting inflammation and regulating the composition and function of gut microbiota.
AuthorsKai Kang, Yue Sun, Dan Pan, Bing Chang, Li-Xuan Sang
JournalJournal of immunology research (J Immunol Res) Vol. 2021 Pg. 5084713 ( 2021) ISSN: 2314-7156 [Electronic] Egypt
PMID33748287 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Kai Kang et al.
Chemical References
  • Anti-Inflammatory Agents
  • Cytokines
  • Fatty Acids, Volatile
  • Pentanoic Acids
  • Niacinamide
  • Dextran Sulfate
  • n-pentanoic acid
Topics
  • Animals
  • Anti-Inflammatory Agents (therapeutic use)
  • Chronic Disease
  • Colitis (therapy)
  • Cytokines (metabolism)
  • Dextran Sulfate
  • Disease Models, Animal
  • Fatty Acids, Volatile (metabolism)
  • Gastrointestinal Microbiome (immunology)
  • Humans
  • Inflammatory Bowel Diseases (therapy)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Niacinamide (therapeutic use)
  • Nutrition Therapy
  • Pentanoic Acids (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: